Loading...
NYSE: SOLV
Solventum Corporation
Healthcare · Medical - Care Facilities
●S&P 500 since 2024
Market Cap
$11.64B
52w High
$88.20
52w Low
$60.70
P/E
7.51
Volume
1.02M
Outstanding Shares
173.49M
Company profile
Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs.
CEOBryan C. Hanson
SectorHealthcare
IndustryMedical - Care Facilities
Employees22,000
IPO dateApr 1, 2024
Valuation
Forward P/E—
EV/EBITDA7.04
Enterprise value$17.95B
Stock splits
No stock splits recorded for this ticker.
Profitability & growth
Revenue growth-3.71%
Gross margin53.47%▼3.92%vs FY2024
Operating margin26.2%▲108.73%vs FY2024
ROE30.82%▲90.38%vs FY2024
Analyst consensus
RatingBuy
Target price$95.80▲42.77%
7
Buy
3
Hold
1
Sell
⚠ Analyst ratings tend to be lagging indicators — upgrades often follow price gains rather than precede them. Use as one signal among many.
Earnings
Last 3 reported quarters plus the next estimate. Switch into compare mode to inspect one metric year-over-year.
Next report
May 14, 2026
View
EPS
Actual vs estimate by quarter
Q2'25
ActualEst.
$1.34
$1.21
Q3FY25
ActualEst.
$1.50
$1.43
Q1'26
ActualEst.
$1.57
$1.50
Q4FY25
Next Est.
—
Revenue
Actual vs estimate by quarter
Q2'25
ActualEst.
$2.07B
$2.02B
Q3FY25
ActualEst.
$2.1B
$2.06B
Q1'26
ActualEst.
$2B
$1.96B
Q4FY25
Next Est.
—